Breakthrough in Glioblastoma: Imvax’s IGV-001 Shows Promise in Clinical Trials
Philadelphia, PA – At the forefront of glioblastoma research, Imvax, Inc. has…
Breakthrough APDS1 Gene Therapy Unveiled by Cellectis
In a remarkable stride forward in biotechnology and medical science, Cellectis and…
Coave Therapeutics Boosts Genetic Medicine with Elite Advisory Board & ALIGATER™ Platform
Introducing the New Scientific Advisory Board at Coave Therapeutics October 12, 2023…
AstraZeneca and Verge AI Collaboration: A $42M Leap in Neurodegenerative R&D
AstraZeneca and Verge Genomics Collaboration: Charting the Future of Neurodegenerative R&D In…
Eterna Therapeutics and Lineage Develop mRNA Gene-Edited iPSC Lines for CNS Diseases
Eterna Therapeutics Inc., a leading innovator in mRNA cell engineering, has recently…
Advancements in K-State Crop Genetics Research: $1.9M NSF Grant Secured
In a major boost to K-State Crop Genetics Research, Kansas State University…
CRISPR Technology Changing Lives: Intellia’s NTLA-2002 Shows Promise for Hereditary Angioedema Treatment
New Hope in CRISPR Genome Editing: Intellia's NTLA-2002 Shows Groundbreaking Potential in…
FDA Approves BioMarin ROCTAVIAN: First Gene Therapy for Severe Hemophilia A
In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has…
Editas Medicine Prices Common Stock Offering at $10.00
A groundbreaking moment in the world of bio-tech as Editas Medicine, a…
MHRA and Genomics England to Launch Revolutionary ‘Biobank’ for Personalized Medicine
The Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England have…